JP2018500878A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018500878A5 JP2018500878A5 JP2017523804A JP2017523804A JP2018500878A5 JP 2018500878 A5 JP2018500878 A5 JP 2018500878A5 JP 2017523804 A JP2017523804 A JP 2017523804A JP 2017523804 A JP2017523804 A JP 2017523804A JP 2018500878 A5 JP2018500878 A5 JP 2018500878A5
- Authority
- JP
- Japan
- Prior art keywords
- glycoprotein
- dengue virus
- antibody
- seq
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462074053P | 2014-11-02 | 2014-11-02 | |
| US62/074,053 | 2014-11-02 | ||
| PCT/US2015/058610 WO2016070178A1 (en) | 2014-11-02 | 2015-11-02 | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018500878A JP2018500878A (ja) | 2018-01-18 |
| JP2018500878A5 true JP2018500878A5 (enExample) | 2018-12-13 |
| JP6671364B2 JP6671364B2 (ja) | 2020-03-25 |
Family
ID=55858450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017523804A Expired - Fee Related JP6671364B2 (ja) | 2014-11-02 | 2015-11-02 | ワクチンおよび診断開発のための組換えデングウイルスについての方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10398768B2 (enExample) |
| EP (1) | EP3212672A4 (enExample) |
| JP (1) | JP6671364B2 (enExample) |
| KR (1) | KR20170075775A (enExample) |
| CN (1) | CN107207619A (enExample) |
| AU (1) | AU2015338859A1 (enExample) |
| BR (1) | BR112017008952A2 (enExample) |
| CA (1) | CA2966198A1 (enExample) |
| MX (1) | MX2017005524A (enExample) |
| MY (1) | MY179251A (enExample) |
| SG (1) | SG11201703366RA (enExample) |
| WO (1) | WO2016070178A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10955414B2 (en) | 2016-08-01 | 2021-03-23 | Inbios International, Inc. | Immunoassay methods and compositions for detecting infection involving use of test antigens as cross-reactive control antigens |
| CN106632620B (zh) * | 2016-11-29 | 2019-08-23 | 菲鹏生物股份有限公司 | 登革病毒重组抗原及其制备方法和应用 |
| WO2018187799A1 (en) * | 2017-04-07 | 2018-10-11 | The Rockefeller University | Compositions and methods related to human neutralizing antibodies to zika and dengue 1 virus |
| CN110568190A (zh) * | 2019-08-30 | 2019-12-13 | 深圳国际旅行卫生保健中心 | 登革热病毒抗原、检测试剂、检测试纸、检测试剂盒及其使用方法 |
| WO2021102363A1 (en) * | 2019-11-20 | 2021-05-27 | The University Of North Carolina At Chapel Hill | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development |
| WO2023178310A1 (en) * | 2022-03-17 | 2023-09-21 | The University Of North Carolina At Chapel Hill | Compositions comprising modified flavivirus e glycoproteins and methods of making and using the same |
| CN116716322B (zh) * | 2023-05-12 | 2024-05-31 | 中山大学 | 一种denv-3全长感染性克隆及其构建方法与应用 |
| WO2024238948A2 (en) * | 2023-05-17 | 2024-11-21 | University Of Iowa Research Foundation | Dengue virus serotype-specific modulation of t cell responses |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4501729A (en) | 1982-12-13 | 1985-02-26 | Research Corporation | Aerosolized amiloride treatment of retained pulmonary secretions |
| US4708871A (en) | 1983-03-08 | 1987-11-24 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| NZ253137A (en) | 1992-06-25 | 1996-08-27 | Smithkline Beecham Biolog | Vaccine comprising antigen and/or antigenic composition, qs21 (quillaja saponaria molina extract) and 3 de-o-acylated monophosphoryl lipid a. |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| AU2003267943C1 (en) * | 2002-02-26 | 2009-05-21 | Altravax, Inc. | Novel flavivirus antigens |
| US7862829B2 (en) | 2004-07-09 | 2011-01-04 | University Of North Carolina At Chapel Hill | Viral adjuvants |
| EP2589602B1 (en) * | 2006-08-15 | 2016-04-06 | The Government of the U.S.A., as repr. by the Secretary, Dept. of Health & Human Services, the Nat. Inst. of Health | Development of dengue virus vaccine components |
| EP2834265A4 (en) * | 2012-04-02 | 2015-10-14 | Univ North Carolina | METHOD AND COMPOSITIONS FOR DENGUE VIRUS EPITOPES |
| CA2918644A1 (en) * | 2013-06-26 | 2014-12-31 | The University Of North Carolina At Chapel Hill | Methods and compositions for dengue virus vaccines |
-
2015
- 2015-11-02 WO PCT/US2015/058610 patent/WO2016070178A1/en not_active Ceased
- 2015-11-02 KR KR1020177014337A patent/KR20170075775A/ko not_active Withdrawn
- 2015-11-02 AU AU2015338859A patent/AU2015338859A1/en not_active Abandoned
- 2015-11-02 MY MYPI2017701472A patent/MY179251A/en unknown
- 2015-11-02 JP JP2017523804A patent/JP6671364B2/ja not_active Expired - Fee Related
- 2015-11-02 CA CA2966198A patent/CA2966198A1/en not_active Abandoned
- 2015-11-02 SG SG11201703366RA patent/SG11201703366RA/en unknown
- 2015-11-02 EP EP15854399.1A patent/EP3212672A4/en not_active Withdrawn
- 2015-11-02 CN CN201580072021.7A patent/CN107207619A/zh active Pending
- 2015-11-02 US US15/523,899 patent/US10398768B2/en not_active Expired - Fee Related
- 2015-11-02 MX MX2017005524A patent/MX2017005524A/es unknown
- 2015-11-02 BR BR112017008952-1A patent/BR112017008952A2/en not_active Application Discontinuation
-
2019
- 2019-08-29 US US16/555,912 patent/US20200230224A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018500878A5 (enExample) | ||
| Fougeroux et al. | Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity | |
| Sun et al. | The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice | |
| CY1124202T1 (el) | Εμβολια ανασυνδυασμενου zika | |
| Pimentel et al. | Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine | |
| Park et al. | Analyzing immune responses to varied mRNA and protein vaccine sequences | |
| JP2015524422A5 (enExample) | ||
| PH12018500199A1 (en) | Antibodies that potently neutralize hepatitis b virus and uses thereof | |
| Carignan et al. | Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine | |
| RU2015155821A (ru) | Вакцины против малярии | |
| ZA202104213B (en) | Antibodies that neutralize hepatitis b virus and uses thereof | |
| Jiang et al. | Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy | |
| NO20090178L (no) | Vaksiner for malaria | |
| BR112014030797A2 (pt) | epítopo de peptídeo isolado, proteína recombinante, molécula de ácido nucléico isolada, vetor, célula hospedeira, método para preparar o epítopo de peptídeo ou mutante do mesmo, vacina de proteína, uso do epítopo de peptídeo ou mutante do mesmo, vacina de gene, uso da molécula de ácido nucléico, composição farmacêutica, anticorpo monoclonal e um fragmento de ligação ao antígeno do mesmo, linha de célula de hibridoma, kit, método para detecção da presença ou nível da proteína hbsag em uma amostra e uso do anticorpo monoclonal ou fragmento de ligação ao antígeno do mesmo | |
| Kim et al. | Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity | |
| Song et al. | Plant‐based, adjuvant‐free, potent multivalent vaccines for avian influenza virus via Lactococcus surface display | |
| RU2021109510A (ru) | Вакцинация с использованием альфа 3 домена mica/b для лечения рака | |
| Davenport et al. | Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease | |
| RU2016133598A (ru) | Композиция микобактериального антигена | |
| JP2017526689A5 (enExample) | ||
| Zhou et al. | An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection | |
| TW202144003A (zh) | 包含固定化病毒粒子之疫苗 | |
| Abente et al. | Alphavirus-vectored hemagglutinin subunit vaccine provides partial protection against heterologous challenge in pigs | |
| JP2016528176A5 (enExample) | ||
| WO2018066999A3 (en) | Chimeric enterovirus virus-like particles |